Edition:
United States

Oncternal Therapeutics Inc (ONCT.PH)

ONCT.PH on Philadelphia Stock Exchange

4.73USD
31 Jul 2019
Change (% chg)

-- (--)
Prev Close
$4.73
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
813
52-wk High
$25.50
52-wk Low
$0.77

Latest Key Developments (Source: Significant Developments)

Oncternal Reports Qtrly Loss Per Share $3.38
Thursday, 8 Aug 2019 04:01pm EDT 

Aug 8 (Reuters) - Oncternal Therapeutics Inc ::ONCTERNAL REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.ONCTERNAL THERAPEUTICS INC - QTRLY LOSS PER SHARE $3.38.  Full Article

Gtx Inc Says Entered Amendment To Agreement & Plan Of Merger & Reorganization With Oncternal Therapeutics & Grizzly Merger Sub
Tuesday, 30 Apr 2019 05:42pm EDT 

April 30 (Reuters) - GTX Inc ::GTX INC - ENTERED AMENDMENT TO AGREEMENT & PLAN OF MERGER & REORGANIZATION WITH ONCTERNAL THERAPEUTICS & GRIZZLY MERGER SUB.GTX - AMENDING EXCHANGE RATIO FORMULA SO FORMER ONCTERNAL STOCKHOLDERS BEFORE MERGER EXPECTED TO OWN ABOUT 77.5% OF OUTSTANDING CAPITAL STOCK OF GTX.  Full Article

GTX Inc Qtrly Loss Per Share $0.62
Tuesday, 15 May 2018 07:00am EDT 

May 15 (Reuters) - GTX Inc ::GTX PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.GTX INC - TOP-LINE RESULTS FROM ASTRID TRIAL EXPECTED EARLY IN Q4 OF 2018.GTX INC - AS OF MARCH 31, 2018, CASH AND SHORT-TERM INVESTMENTS WERE $32.1 MILLION COMPARED TO $43.9 MILLION AT DECEMBER 31, 2017.GTX INC - QTRLY LOSS PER SHARE $0.62.  Full Article

GTX reports qtrly ‍loss per share $0.53​
Tuesday, 14 Nov 2017 04:05pm EST 

Nov 14 (Reuters) - Gtx Inc ::GTX provides corporate update and reports third quarter 2017 financial results.GTX Inc qtrly ‍loss per share $0.53​.  Full Article

GTX Inc files for offering of up to 8.8 million shares of common stock
Friday, 20 Oct 2017 04:50pm EDT 

Oct 20 (Reuters) - GTX Inc ::GTX Inc files for offering of up to 8.8 million shares of common stock by the selling stockholders .  Full Article

Amzak Health Investors Llc reports 6.15 pct passive stake in GTX as of Sept 29
Tuesday, 10 Oct 2017 04:42pm EDT 

Oct 10 (Reuters) - GTX Inc :Amzak Health Investors Llc reports 6.15 percent passive stake in GTX Inc as of September 29 - SEC Filing‍​.  Full Article

Aisling capital IV LP reports 6.2 pct passive stake in GTX as of Sept 29
Thursday, 5 Oct 2017 04:13pm EDT 

Oct 5 (Reuters) - GTX Inc :Aisling Capital IV LP reports 6.2 percent passive stake in GTX Inc as of Sept 29 - SEC Filing.  Full Article

GTx announces $48.5 million private placement
Tuesday, 26 Sep 2017 07:30am EDT 

Sept 26 (Reuters) - Gtx Inc :GTx announces $48.5 million private placement.GTx - ‍entered into agreement for sale of its common stock & warrants to purchase common stock in private placement with gross proceeds of $48.5 million.GTx -under terms of agreement, at close of placement, co will issue, sell 5.5 million shares to purchase up to 3.3 million additional shares of common stock.GTx Inc - co ‍to purchase up to 3.3 million additional shares of common stock at a per unit purchase price of $8.845​.  Full Article

GTx announces positive results from enobosarm Phase 2 proof-of-concept clinical trial
Wednesday, 13 Sep 2017 07:00am EDT 

Sept 13 (Reuters) - Gtx Inc :GTx announces positive results from enobosarm phase 2 proof-of-concept clinical trial in women with stress urinary incontinence.GTx Inc - ‍clinically significant reductions in incontinence episodes per day in all patients completing 12 week treatment​.GTx Inc - ‍reductions in incontinence episodes were sustained for up to 7 months following completion of enobosarm treatment​.GTx Inc - ‍mean stress leaks decreased by 83 percent from baseline over 12 weeks in study​.GTx Inc - ‍at all evaluated dose levels, enobosarm was observed to be generally safe and well tolerated​.  Full Article